Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study

Table 1 Clinical and demographic characteristics of the patients

Characteristic	Patients with RA	RA control group
Number of patients	57	55
Mean age, years (range)	56 (28–83)	63 (30–83)
Sex (F/M)	53/4	45/10
Disease duration, years (range)	8 (1–27)	6 (1–25)
Adalimumab treatment, n	57	0
Concomitant medications:
NSAID	48	34
Corticosteroids	42	30
Methotrexate	57	55
Other	6	0

ISSN: 1478-6362